Jonathan I. Silverberg
Tracked across 2 events · 13 articles · First seen May 28, 2026 · Last active Sep 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Jonathan I. Silverberg is the lead investigator of the study, emphasizing that Atopic dermatitis is a chronic disease with lasting consequences on life trajectories.
May 28, 2026 · 7 articles
Business
Impact: Jonathan I. Silverberg, co-founder of Multiplier and former director of the United States — United States Department of Energy's Loan Programs Office, is mentioned as an advisor.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Jonathan I. Silverberg live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard